MarketPeel
Insider Trading Intelligence
Pricing
…
KS

Kathleen Sebelius

HUMA
DIRECTOR · HUMACYTE, INC. · CIK 0001654316
FILING MIX · LIFETIME67%/33%
BUYS
20
SELLS
10
TOTAL VALUE
$385.3K
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
112,671
AVG SELL PX
$12.57
TRADE KIND
SHOWING 30 / 30
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kathleen Sebelius, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+11.05%+4.50%+6.55%-2.98%—
14d3+33.33%+17.42%+5.01%+12.41%+12.15%—
30d3+33.33%+5.55%+8.14%-2.59%+0.41%—
60d3+33.33%+48.47%+13.12%+35.35%+0.76%—
90d3+100.00%+16.13%+15.35%+0.78%-30.24%—
180d3+100.00%+8.71%+13.63%-4.92%-47.57%—
1y3+66.67%-62.31%+25.37%-87.67%-91.78%—
2y3(3 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HUMA · 80,000 shares · as of Jun 11, 2026
037,00674,013111,019148,02520222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 20 buys / 10 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jun 11, 2026Jun 12, 2026 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
56,818$0.88$50.0K148,025May 19, 2026May 20, 2026 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jun 12, 2025Jun 16, 2025 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
50,000$1.32$66.0K91,207Apr 8, 2025Apr 8, 2025 ↗View →
HUMA
HUMACYTE, INC.
SALE
3,634$5.41$19.7K40,276Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
4,521——3,979Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
2,479——6,021Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
4,521$4.34$19.6K43,910Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
1,548$5.39$8.3K41,207Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
2,479$3.35$8.3K42,755Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
39,389$2.56$100.8K39,389Jun 14, 2024Jun 17, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
39,389——0Jun 14, 2024Jun 17, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
50,000——50,000Jun 13, 2024Jun 17, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
6,889——31,888Jun 13, 2024Jun 17, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
7,672——32,671Jun 13, 2024Dec 20, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Jun 15, 2023Jun 16, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
3,599——24,999Jun 8, 2023Jun 12, 2023 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Jun 9, 2022Jun 13, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
7,523——21,400Jun 9, 2022Jun 13, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Oct 13, 2021Oct 15, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
39,389——39,389Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
17,068——17,068Aug 26, 2021Aug 27, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
2,699——13,877Jun 30, 2021Jul 2, 2021 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
420——11,178Oct 22, 2020Oct 23, 2020 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
2,558——10,758Jul 23, 2020Jul 24, 2020 ↗View →
DERM
JOURNEY MEDICAL CORP
SALE
6,896——0Feb 20, 2020Feb 24, 2020 ↗View →
DERM
JOURNEY MEDICAL CORP
SALE
6,000$18.75$112.5K0Feb 20, 2020Feb 24, 2020 ↗View →
DERM
JOURNEY MEDICAL CORP
SALE
20,689——0Feb 20, 2020Feb 24, 2020 ↗View →
DERM
JOURNEY MEDICAL CORP
SALE
3,000——0Feb 20, 2020Feb 24, 2020 ↗View →
DERM
JOURNEY MEDICAL CORP
SALE
6,000——0Feb 20, 2020Feb 24, 2020 ↗View →
Other insiders · HUMA
Loading peer insiders…
About this filer
CIK 0001654316
ROLE
Director
PRIMARY
HUMA
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001654316DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback